The dual antioxidant chitosan oligosaccharides regulate the transdifferentiation of lung effector cells in the management of idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal disease with limited treatment options. This study investigates the therapeutic potential of chitosan oligosaccharides (COS), a natural carbohydrate with antioxidant properties, in comparison to the FDA-approved drug pirfenidone (PFD). B...
Saved in:
| Main Authors: | Huan He, Youtao Xu, Xinru Chen, Jiawen Wu, Xianpeng Zhong, Xiyu Li, Jing Qiao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | Carbohydrate Polymer Technologies and Applications |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666893925001203 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ferroptosis: the potential key roles in idiopathic pulmonary fibrosis
by: Longfei Song, et al.
Published: (2025-04-01) -
Chito-oligosaccharide impairs the proliferation, invasion and migration of pancreatic cancer cells
by: Han Liu, et al.
Published: (2025-03-01) -
Carboxymethyl chitosan oligosaccharide prevents the progression of chronic kidney disease as a Nrf2-dependent apoptosis inhibitor
by: Xiaozheng Yuan, et al.
Published: (2025-03-01) -
Targeting E3 ubiquitin ligases: a new frontier in idiopathic pulmonary fibrosis treatment
by: Kun Zhang, et al.
Published: (2025-08-01) -
Mechanism of Histone Deacetylase Inhibitors for Treatment of Idiopathic Pulmonary Fibrosis
by: ZHOU Jia, et al.
Published: (2025-02-01)